{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-15",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Neuville Sur Oise",
      "state": "N/A",
      "country": "France",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Devices",
      "event_id": "79797",
      "recalling_firm": "Hyphen BioMed",
      "address_1": "155 rue d Eragny",
      "address_2": "N/A",
      "postal_code": "N/A",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "E-Mail",
      "distribution_pattern": "OH, MD, NC, NY, NH, Canada, Sweden",
      "recall_number": "Z-1744-2018",
      "product_description": "ZYMUTEST HIA IgGAM; REF Number: RK040D; UDI: 03663537018770 a qualitative screening assay intended for the global detection of heparin- dependent antibodies, whether the isotype is: IgG, IgM and IgA, in human plasma, by clinical laboratories.",
      "product_quantity": "281",
      "reason_for_recall": "Incorrect package insert indicating use of the kits with plasma, serum, and other biological fluids. The kits should only be used with plasma.",
      "recall_initiation_date": "20180205",
      "center_classification_date": "20180508",
      "termination_date": "20180816",
      "report_date": "20180516",
      "code_info": "Lot numbers: F1600568P1, F1600568P2, F1700415P1, F1700415P2, F1701369P1, F1701369P2"
    }
  ]
}